SCHEMBL1104944

SCHEMBL1104944

Cc1ccc2c(c1)C(C)(C)c1cc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccncc45)cc3)ccc1-2

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PDK2 Q15119 5/20 0.36
PGR P06401 1/20 0.36
MAP2 P11137 1/20 0.34
DHODH Q02127 3/20 0.33
PIK3CD O00329 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP17A1 P05093 1/20 0.33
FLT3 P36888 1/20 0.33
TNF P01375 1/20 0.33
DGAT2 Q96PD7 1/20 0.32
BCHE P06276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104948 0.96 LMNA (0.39) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL10072719 0.96 PDK2 (0.39) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL1102678 0.94 PDK2 (0.39) PDK2MAP2DHODHPIK3CDALOX5
SCHEMBL16298678 0.93 LMNA (0.37) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL1102686 0.93 PDK2 (0.38) PDK2MAP2DHODHPIK3CDALOX5
SCHEMBL1102542 0.92 PDK2 (0.39) PDK2MAP2DHODHPIK3CDALOX5
SCHEMBL1102799 0.91 PDK2 (0.42) PDK2MAP2PIK3CDALOX5TNF
SCHEMBL1102673 0.90 PDK2 (0.37) PDK2MAP2DHODHPIK3CDALOX5
SCHEMBL16298676 0.88 PDK2 (0.41) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL1102593 0.88 PDK2 (0.42) PDK2MAP2DHODHPIK3CDALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 KDM4E 3367/4885MEN1 4462/4885ALDH1A1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.